Tuberculosis and tumour necrosis factor-α inhibitor therapy: a report of three cases in patients with psoriasis. Comprehensive screening and therapeutic guidelines for clinicians
Authors:
- 1 January 2009
- journal article
- case report
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 160 (1) , 8-15
Abstract
Tumour necrosis factor (TNF)-alpha inhibitors, long used in rheumatology and gastroenterology, have made a significant impact on the therapy of psoriasis and psoriatic arthritis. TNF-alpha is an important cytokine in normal physiological processes such as the immune response to granulomatous infection. Inhibition of this process by TNF-alpha inhibitors has been reported to increase the susceptibility of patients to granulomatous infections such as Mycobacterium tuberculosis. Despite the numerous reported cases in the literature and appropriate warnings on the labels for the three currently approved TNF-alpha inhibitors, current guidelines do not address case-specific issues across the full spectrum of tuberculosis. The probability of developing active tuberculosis has been reported to be as much as seven times higher when recommendations are not followed. We report three cases of tuberculosis induced by TNF-alpha inhibitors despite a rigorous screening policy in our tertiary care psoriasis centre, and suggest tuberculosis-specific guidelines for clinicians using these agents based on a review of the literature.Keywords
This publication has 29 references indexed in Scilit:
- Evaluation of latent tuberculosis infection in patients with inflammatory arthropathies before treatment with TNF- blocking drugs using a novel flow-cytometric interferon- release assayRheumatology, 2007
- Risk of tuberculosis in patients treated with tumor necrosis factor antagonists due to incomplete prevention of reactivation of latent infectionArthritis Care & Research, 2007
- Meta-analysis: New Tests for the Diagnosis of Latent Tuberculosis Infection: Areas of Uncertainty and Recommendations for ResearchAnnals of Internal Medicine, 2007
- Latent Tuberculosis in HIV positive, diagnosed by the M. Tuberculosis Specific Interferon-γ testRespiratory Research, 2006
- Use of a T-cell-based test for detection of tuberculosis infection among immunocompromised patients: Table 1—European Respiratory Journal, 2006
- Evaluation of an In Vitro Assay for Interferon Production in Response to the Mycobacterium tuberculosis- Synthesized Peptide Antigens ESAT-6 and CFP-10 and the PPD Skin TestAmerican Journal of Clinical Pathology, 2006
- Cost-effectiveness of tuberculosis control strategies among immigrants and refugeesEuropean Respiratory Journal, 2005
- Control and prevention of tuberculosis in the United Kingdom: Code of Practice 2000Thorax, 2000
- Diagnostic Standards and Classification of Tuberculosis in Adults and Children: This Official Statement of the American Thoracic Society and the Centers for Disease Control and Prevention was Adopted by the ATS Board of Directors, July 1999. This Statement was endorsed by the Council of the Infectious Disease Society of America, September 1999American Journal of Respiratory and Critical Care Medicine, 2000
- Targeted Tuberculin Testing and Treatment of Latent Tuberculosis InfectionAmerican Journal of Respiratory and Critical Care Medicine, 2000